UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
Yochai Wolf(Harvard University), Yardena Samuels(Weizmann Institute of Science), Alejandro Jiménez-Sánchez(University of Cambridge), Eli Pikarsky(Hadassah Medical Center), Glenn Merlino(National Cancer Institute), Yishai Levin(Weizmann Institute of Science), Kevin Litchfield(The Francis Crick Institute), Charles Swanton(Cancer Research UK), Hiren Karathia(National Cancer Institute), Sophie Trabish(Weizmann Institute of Science), Osnat Bartok(Weizmann Institute of Science), Eilon Barnea(Technion – Israel Institute of Technology), Einat Cinnamon(The Francis Crick Institute), Gitit Bar Eli(Weizmann Institute of Science), Joo Sang Lee(National Institutes of Health), Sapir Cohen(Weizmann Institute of Science), Ronen Levy(Weizmann Institute of Science), Ilan Stein(Hadassah Medical Center), Shai S. Shen-Orr(Stanford University), Eytan Ruppin(National Institutes of Health), Sushant Patkar(National Institutes of Health), Martin L. Miller(Cancer Research UK), Eva Pérez‐Guijarro, Adam Solomon(Weizmann Institute of Science), Tania Dubovik(Technion – Israel Institute of Technology), Arie Admon(Technion – Israel Institute of Technology), Chi‐Ping Day(National Cancer Institute), Lea Eisenbach(Weizmann Institute of Science), Lital Bitton(Weizmann Institute of Science)
Cited by 394
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
|Science Signaling|2010|1.5k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
|Genome biology|2016|1.3k
TIM3 comes of age as an inhibitory receptor
|Nature reviews. Immunology|2019|937